Trial Profile
A Phase I/II, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Systemic Absorption and Dihydropyrimidine Dehydrogenase (DPD) Enzyme Activity Following Repeated Topical Applications of Brivudin Cream 0.5% and 1.0% in Patients with Herpes Simplex Labialis (HSL).
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Brivudine (Primary)
- Indications Herpes labialis
- Focus Therapeutic Use
- Sponsors Menarini Ricerche
- 02 Apr 2022 Status changed from recruiting to completed.
- 14 Jun 2011 New trial record